{"nct_id":"NCT01855711","title":"Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)","status":"COMPLETED","status_verified_date":"2017-04","start_date":"2003-09-18","start_date_type":"ACTUAL","primary_completion_date":"2005-05-10","primary_completion_date_type":"ACTUAL","completion_date":"2005-05-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}